Summary
This prediction ended on 10.01.11 with a price of €15.43. With a performance of -7.39%, the BUY prediction by melinda finished with a loss. melinda has a follow-up prediction for QIAGEN NV where he still thinks QIAGEN NV is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| QIAGEN NV | - | - | - | - |
| iShares Core DAX® | -1.111% | 0.196% | 1.211% | 51.832% |
| iShares Nasdaq 100 | -4.346% | -3.249% | 25.873% | 80.642% |
| iShares Nikkei 225® | -6.785% | -7.717% | 50.968% | 69.238% |
| iShares S&P 500 | -1.788% | 0.993% | 21.073% | 67.424% |
According to melinda what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread QIAGEN NV diskutieren
Biotechnologie
QIAGEN Marktführer in manuellen und automatisierten Aufreinigung von Nukleinsäuren ACDE Life-Science-Produkten für den Nachweis menschlicher Krankheitserreger
(Laufzeit überschritten)